Search-Results

Search Results

Showing results 611-620 / 1463

Human resources policies

Explore

Bitrex helps ensure good fit for vital PPE

News: As personal protective equipment (PPE) becomes more important than ever, a Johnson Matthey product is helping ensure face masks are protecting their wearers as much as possible.

Explore

Johnson Matthey releases Platinum 2013

Johnson Matthey's latest review of supply and demand in the platinum group metals markets, Platinum 2013, is released today at the start of London Platinum Week

Explore

Delay to the publication of preliminary financial results

Explore

First license of more sustainable isononyl alcohol production process to be in China

News: Dow and Johnson Matthey today announced that Zibo Qixiang Tengda Chemical Company, Ltd. has selected LP OxoSM Technology to produce isononyl alcohol (INA) at its new manufacturing facility.

Explore

Johnson Matthey taps Kebotix’s AI capabilities to enhance digital strategy

Explore

The elements of life: catalysing pharmaceutical innovation

JM's Ahir Pushpanath gives a fascinating insight into JM's developments in biocatalysis as he explores how enzymes' unique catalytic abilities drive science by connecting essential life elements.

Explore

Johnson Matthey adds support to UK All-Party Parliamentary Group on Hydrogen

News: Johnson Matthey (JM), a global leader in sustainable technologies, is pleased to announce that it has joined the All-Party Parliamentary Group (APPG) on Hydrogen and, along with other leading companies in hydrogen, will be supporting its secretariat.

Explore

Independent trials confirm greater benefits of HTX thermocouple wire over conventional thermocouples

News: Independent trials at the UK’s National Measurement Institute, NPL, confirm that HTX thermocouple wire maintains its accuracy for longer than conventional thermocouples.

Explore

JM to manufacture regulatory starting materials for Sarepta Therapeutics

News: Johnson Matthey to manufacture regulatory starting materials for Sarepta Therapeutics’ RNA technology-based clinical and commercial programmes.

Explore